research use only

Albendazole ADC Cytotoxin inhibitor

Cat.No.S1640

Albendazole is a member of the benzimidazole compounds used as a drug indicated for the treatment of a variety of worm infestations.
Jump to

Quality Control

Batch: Purity: 99.88%
99.88

Solubility

In vitro
Batch:

DMSO : 17 mg/mL (64.07 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 265.33 Formula

C12H15N3O2S

Storage (From the date of receipt)
CAS No. 54965-21-8 Download SDF Storage of Stock Solutions

Synonyms SKF-62979 SMILES CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC

Read more about storage stability stock solution CAS number SMILES

Mechanism of Action

Targets/IC50/Ki
tubulin
In vitro
Albendazole is reported to be teratogenic in rats, and is extensively metabolized to the sulfoxide derivative. This compound and its sulfoxide metabolite elicit an accumulation of cells in the mitotic phase of the cell cycle.
In vivo
Albendazole causes an induction of hepatic activities of CYP1A1-associated ethoxyresorufin O-deethylase (EROD) 65 fold, CYP1A2-associated methoxyresorufin O-demethylase (MROD) 6 fold, CYP2B1-associated penthoxyresorufin O-dealkylase (PROD) 4 fold, CYP2B2-associated benzyloxyresorufin O-dealkylase (BROD) 14 fold, as well as a partial reduction of CYP2E1-associated 4-nitrophenol hydroxylase (4-NPH) activity in the rat. This compound is metabolized to its pharmacologically active sulfoxide metabolites by liver and lung microsomes from sheep and cattle, as well as by cattle intestinal microsomes. This benzimidazole derivative has a broad spectrum of activity against human and animal helminthe parasites. It and its metabolites are extensively distributed to the digestive tract, mainly into the abomasal fluid, after the i.v. and i.r. administrations. This compound and its active albendazole sulphoxide (ABZSO) metabolite are recovered in tapeworms collected from both i.v. and i.r. treated lambs.
References
  • [4] https://pubmed.ncbi.nlm.nih.gov/12480310/
  • [5] https://pubmed.ncbi.nlm.nih.gov/10372592/

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-05-01)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06565507 NOT_YET_RECRUITING
Brain Cysticercosis
Universidad Peruana Cayetano Heredia
2026-12-01 PHASE2; PHASE3
NCT07707817 RECRUITING
Onchocerciasis (River Blindness); Schistosomiasis; Soil Transmitted Helminth (STH) Infections; Lymphatic Filariasis
Uwemedimo Friday Ekpo
2026-07-01
NCT07159373 NOT_YET_RECRUITING
Lymphatic Filariasis; Scabies; Strongyloidiasis
Medicines Development for Global Health
2026-03 PHASE3
NCT07661316 NOT_YET_RECRUITING
Trichuriasis; Strongyloidiasis; Ascariasis; Hookworm Infection; Soil-Transmitted Helminthiasis
Mundo Sano Foundation
2026-11-01 PHASE3
NCT04713787 RECRUITING
Trichuriasis
Asociacion Benefica Prisma
2024-09-07 PHASE2
NCT07258173 NOT_YET_RECRUITING
Trichuris Infection
Jennifer Keiser
2026-11-15 PHASE2

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.